Anlon Healthcare Limited has informed the Exchange regarding 'continuation of our earlier intimation dated December 02, 2025 regarding the execution of Share Purchase Agreement dated December 2, 2025'.
AHCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anlon Healthcare Limited has completed the acquisition of a 67.48% equity stake in Apiqo Organics Private Limited (formerly M/s Apple Life Science) as of January 9, 2026. This is a continuation of the Share Purchase Agreement signed on December 2, 2025. Following the acquisition, Apiqo Organics has become a subsidiary of Anlon Healthcare. The acquisition was carried out in compliance with Section 179(3) of the Companies Act, 2013. Further details were already disclosed in the company's earlier filing dated December 2, 2025.
This acquisition expands Anlon Healthcare's business footprint by adding a new subsidiary, which could contribute to future revenue and earnings consolidation. Shareholders should expect this to be reflected in the company's consolidated financials going forward.